Key result
The mDASHNa-CC smartphone app is being evaluated in a pilot randomized controlled trial to determine its feasibility and usability for supporting healthy diet and hypertension control in Chinese Canadian seniors.
Why the study?
To design and test the usability and feasibility of a smartphone-based dietary educational app to support a healthy diet and hypertension control among Chinese Canadian seniors.
Does the mDASHNa-CC smartphone app demonstrate feasibility, acceptability, and preliminary effectiveness for hypertension control in Chinese Canadian seniors?
RCT (n=60)
Single-blind
1:1 online randomization
No
Does the mDASHNa-CC smartphone app demonstrate feasibility, acceptability, and preliminary effectiveness for hypertension control in Chinese Canadian seniors?
This protocol outlines a mixed-methods study to design and test the feasibility of a culturally tailored smartphone app incorporating the DASH diet, sodium reduction, and traditional Chinese medicine for hypertension self-management in Chinese Canadian seniors.
Pilot RCT will test feasibility of culturally tailored app for hypertension self-management in Chinese Canadian seniors; extends digital health research to this ethnic group.
BACKGROUND: This proposed study aims to translate the Dietary Approach to Stop Hypertension with Sodium (Na) Reduction for Chinese Canadians (DASHNa-CC), a classroom-based, antihypertensive, dietary educational intervention, to an innovative smartphone app (mDASHNa-CC). This study will enable Chinese Canadian seniors to access antihypertensive dietary interventions anytime, regardless of where they are. It is hypothesized that senior Chinese Canadians will be satisfied with their experiences using the mDASHNa-CC app and that the use of this app could lead to a decrease in their blood pressure and improvement in their health-related quality of life. OBJECTIVE: The goal of this study is to design and test the usability and feasibility of a smartphone-based dietary educational app to support a healthy diet and hypertension control for Chinese Canadian seniors. METHODS: A mixed-method two-phase design will be used. The study will be conducted in a Chinese immigrant community in Toronto, Ontario, Canada. Chinese Canadian seniors, who are at least 65 years old, self-identified as Chinese, living in Canada, and with elevated blood pressure, will be recruited. In Phase I, we will design and test the usability of the app using a user-centered approach. In Phase II, we will test the feasibility of the app, including implementation (primary outcomes of accrual and attrition rates, technical issues, acceptability of the app, and adherence to the intervention) and preliminary effectiveness (secondary outcomes of systolic and diastolic blood pressure, weight, waist circumference, health-related quality of life, and health service utilization), using a pilot, two-group, randomized controlled trial with a sample size of 60 participants in a Chinese Canadian community. RESULTS: The study is supported by the Startup Research Grant from Nipissing University, Canada. The research ethics application is under review by a university research ethics review board. CONCLUSIONS: The study results will make several contributions to the existing literature, including illustrating the rigorous design and testing of smartphone app technology for hypertension self-management in the community, exploring an approach to incorporating traditional medicine into chronic illness management in minority communities and promoting equal access to current technology among minority immigrant senior groups. TRIAL REGISTRATION: Clinicaltrials.gov NCT03988894; https://clinicaltrials.gov/ct2/show/NCT03988894. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/15545.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2020) conducted an RCT in Hypertension (n=60). mDASHNa-CC smartphone app vs. Usual care was evaluated on Feasibility and implementation (accrual and attrition rates, technical issues, acceptability, and adherence). The mDASHNa-CC smartphone app is being evaluated in a pilot randomized controlled trial to determine its feasibility and usability for supporting healthy diet and hypertension control in Chinese Canadian seniors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: